{
    "organizations": [],
    "uuid": "f408d10a280c91a85f5d140e3ceb7079dd64fae1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vifor-pharma-says-us-fda-approves/brief-vifor-pharma-says-us-fda-approves-use-of-veltassa-with-or-without-food-idUSASO0004HF",
    "ord_in_thread": 0,
    "title": "BRIEF-Vifor Pharma Says US FDA Approves Use Of Veltassa With Or Without Food",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Vifor Pharma AG:\n* US FDA APPROVES USE OF VELTASSAÂ® WITH OR WITHOUT FOOD * VIFOR PHARMA AG - UPDATED LABEL MAY ALLOW FOR INCREASED DOSING FLEXIBILITY FOR PATIENTS WITH HYPERKALAEMIA Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-05-08T13:14:00.000+03:00",
    "crawled": "2018-05-09T12:46:02.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "vifor",
        "pharma",
        "ag",
        "u",
        "fda",
        "approves",
        "use",
        "without",
        "food",
        "vifor",
        "pharma",
        "ag",
        "updated",
        "label",
        "may",
        "allow",
        "increased",
        "dosing",
        "flexibility",
        "patient",
        "hyperkalaemia",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}